Cover ofPiHKAL, 1st ed. | |
| Author | Alexander andAnn Shulgin |
|---|---|
| Subject | Pharmacology,Autobiography,Psychoactive drugs |
| Publisher | Transform Press |
Publication date | 1991 |
| Publication place | United States |
| Media type | Paperback |
| ISBN | 0-9630096-0-5 |
| OCLC | 269100404 |
| Followed by | TiHKAL (1997) |
PiHKAL: A Chemical Love Story, also known asPhenethylamines I Have Known and Loved, is abook byAlexander Shulgin andAnn Shulgin published in 1991.[1][2][3] The subject of the work ispsychoactivephenethylaminechemical derivatives, notably those that act aspsychedelics and/orentactogens.[2][3] The book has two halves, with the second part containing detailed entries on 179 phenethylamines.[2][3]PiHKAL was followed byTiHKAL: The Continuation (Tryptamines I Have Known and Loved) (1997).[4][5]
The book is arranged into two parts, the first part being a fictionalizedautobiography of the couple and the second part describing 179 different psychedelic compounds (most of which Shulgin discovered himself), including detailedsynthesis instructions,bioassays, doses,durations, and other commentary.[2][3]
The second part was made freely available by Shulgin onErowid while the first part is available only in the printed text. While the reactions described are beyond the ability of people with a basic chemistry education, some tend to emphasize techniques that do not require difficult-to-obtain chemicals.[3] Notable among these are the use ofmercury-aluminium amalgam (an unusual but easy to obtainreagent) as areducing agent and detailed suggestions on legal plant sources of important drug precursors such assafrole.[3]
Members of Shulgin's research who contributed to the experience reports included Shulgin himself,Ann Shulgin,Myron Stolaroff, and Jean Stolaroff, among others.[6][7]
ThroughPiHKAL (and laterTiHKAL), Shulgin sought to ensure that his discoveries would escape the limits of professional research labs and find their way to the public, a goal consistent with his stated beliefs thatpsychedelic drugs can be valuable tools for self-exploration. TheMDMA ("ecstasy") synthesis published inPiHKAL remains one of the most commonclandestine methods of its manufacture to this day. Many countries have banned the major substances for which this book gives directions for synthesis, such as2C-B,2C-T-2, and2C-T-7.[8]
In 1994, two years afterPiHKAL was published, theDrug Enforcement Administration (DEA) raided Shulgin's laboratory and requested that he surrender his DEA license. Richard Meyer, spokesman for DEA's San Francisco Field Division, has stated in reference toPiHKAL "It is our opinion that those books are pretty much cookbooks on how to make illegal drugs. Agents tell me that in clandestine labs that they have raided, they have found copies of those books", suggesting that the publication ofPiHKAL and the termination of Shulgin's license may have been related.[9]
Some compounds inPiHKAL, likemescaline,DOM,2C-B,MDA, andMDMA, are widely known and/or usedpsychedelics and/orentactogens.[3]
The "Essential Amphetamines" are what Shulgin describes as ten amphetamines that differ from natural products such assafrole ormyristicin by an amine group (PiHKAL Entry #157 TMA).[3] The list consists of:[3]
Not all of these chemicals are bioassayed inPiHKAL; some are merely mentioned.[3]
The so-called "magical half-dozen" refers to Shulgin's self-rated most important phenethylamine compounds, all of which except mescaline he developed and synthesized himself.[3] They are found within the first book ofPiHKAL, and are as follows:[3]
All six are now Schedule I controlled substances in the United States.[10]
Shulgin systematically replaced the 10 uniquehydrogen atoms in DOM withmethyl groups in order to explore its activity and named these compounds the 10 classic ladies.[11][3] The resulting compounds were as follows:[11][3]
As with the essential amphetamines, not all of these compounds have been bioassayed.[3]
Some additional "ladies" have also since been named, includingJulia (DOTMA; 3,6-dimethyl-DOM),Jelena (2C-IP), andSelene (2C-P).[11][12]
| # | Substance | Chemical name | Group | Dosea | Duration | Link |
|---|---|---|---|---|---|---|
| 1 | AEM (α-ethylmescaline) | α-Ethyl-3,4,5-trimethoxy-PEA | 4C-scaline | >220 mg | Unknown | [1] |
| 2 | AL (allylescaline) | 4-Allyloxy-3,5-dimethoxy-PEA | Scaline | 20–35 mg | 8–12 hours | [2] |
| 3 | ALEPH (DOT, para-DOT) | 4-Methylthio-2,5-dimethoxy-A | DOx | 5–10 mg | 6–8 hours | [3] |
| 4 | ALEPH-2 | 4-Ethylthio-2,5-dimethoxy-A | DOx | 4–8 mg | 8–16 hours | [4] |
| 5 | ALEPH-4 | 4-Isopropylthio-2,5-dimethoxy-A | DOx | 7–12 mg | 12–20 hours | [5] |
| 6 | ALEPH-6 | 4-Phenylthio-2,5-dimethoxy-A | DOx | >40 mg | "Probably long" | [6] |
| 7 | ALEPH-7 | 4-Propylthio-2,5-dimethoxy-A | DOx | 4–7 mg | 15–30 hours | [7] |
| 8 | ARIADNE (4C-D; Dimoxamine) | 2,5-Dimethoxy-α-ethyl-4-methyl-PEA | 4C | Unknownb | Short | [8] |
| 9 | ASB (asymbescaline) | 3,4-Diethoxy-5-methoxy-PEA | Scaline (mod.) | 200–280 mg | 10–15 hours | [9] |
| 10 | B (buscaline) | 4-Butoxy-3,5-dimethoxy-PEA | Scaline | >150 mg | "Several hours" | [10] |
| 11 | BEATRICE (N-methyl-DOM) | 2,5-Dimethoxy-4,N-dimethyl-A | DOx | >30 mg | 6–10 hours | [11] |
| 12 | Bis-TOM | 2,5-Bismethylthio-4-methyl-A | DOx (mod.) | >160 mg | Unknown | [12] |
| 13 | BOB (β-methoxy-2C-B) | 4-Bromo-2,5,β-trimethoxy-PEA | BOx, 2C | 10–20 mg | 10–20 hours | [13] |
| 14 | BOD (β-methoxy-2C-D) | 2,5,β-Trimethoxy-4-methyl-PEA | BOx, 2C | 15–25 mg | 8–16 hours | [14] |
| 15 | BOH (β-methoxy-MDPEA) | β-Methoxy-3,4-methylenedioxy-PEA | BOx, MDxx | 80–120 mg | 6–8 hours | [15] |
| 16 | BOHD (β-hydroxy-2C-D) | 2,5-Dimethoxy-β-hydroxy-4-methyl-PEA | BOx, 2C | >50 mg | Unknown | [16] |
| 17 | BOM (β-methoxymescaline) | 3,4,5,β-Tetramethoxy-PEA | BOx, scaline | >200 mg | Unknown | [17] |
| 18 | 4-Br-3,5-DMA | 4-Bromo-3,5-dimethoxy-A | 3C-scaline | 4–10 mg | 8–12 hours | [18] |
| 19 | 2-Br-4,5-MDA | 2-Bromo-4,5-methylenedioxy-A | MDxx | 350 mg | Unknown | [19] |
| 20 | 2C-B | 4-Bromo-2,5-dimethoxy-PEA | 2C | 12–24 mg | 4–8 hours | [20] |
| 21 | 3C-BZ (3C-benzscaline) | 4-Benzyloxy-3,5-dimethoxy-A | 3C-scaline | 25–200 mg | 18–24 hours | [21] |
| 22 | 2C-C | 4-Chloro-2,5-dimethoxy-PEA | 2C | 20–40 mg | 4–8 hours | [22] |
| 23 | 2C-D | 4-Methyl-2,5-dimethoxy-PEA | 2C | 20–60 mg | 4–6 hours | [23] |
| 24 | 2C-E | 4-Ethyl-2,5-dimethoxy-PEA | 2C | 10–25 mg | 8–12 hours | [24] |
| 25 | 3C-E (3C-escaline) | 4-Ethoxy-3,5-dimethoxy-A | 3C-scaline | 30–60 mg | 8–12 hours | [25] |
| 26 | 2C-F | 4-Fluoro-2,5-dimethoxy-PEA | 2C | >250 mg | Unknown | [26] |
| 27 | 2C-G | 3,4-Dimethyl-2,5-dimethoxy-PEA | 2C | 20–35 mg | 18–30 hours | [27] |
| 28 | 2C-G-3 | 3,4-Trimethylene-2,5-dimethoxy-PEA | 2C (mod.) | 16–25 mg | 12–24 hours | [28] |
| 29 | 2C-G-4 | 3,4-Tetramethylene-2,5-dimethoxy-PEA | 2C (mod.) | Unknown | Unknown | [29] |
| 30 | 2C-G-5 | 3,4-Norbornyl-2,5-dimethoxy-PEA | 2C (mod.) | 10–16 mg | 32–48 hours | [30] |
| 31 | 2C-G-N | 1,4-Dimethoxynaphthyl-2-ethylamine | 2C (mod.) | 20–40 mg | 20–30 hours | [31] |
| 32 | 2C-H (2,5-DMPEA) | 2,5-Dimethoxy-PEA | 2C | Unknown | Unknown | [32] |
| 33 | 2C-I | 4-Iodo-2,5-dimethoxy-PEA | 2C | 14–22 mg | 6–10 hours | [33] |
| 34 | 2C-N | 4-Nitro-2,5-dimethoxy-PEA | 2C | 100–150 mg | 4–6 hours | [34] |
| 35 | 2C-O-4 | 4-Isopropoxy-2,5-dimethoxy-PEA | 2C | >60 mg | Unknown | [35] |
| 36 | 2C-P | 4-Propyl-2,5-dimethoxy-PEA | 2C | 6–10 mg | 10–16 hours | [36] |
| 37 | CPM (cyclopropylmescaline) | 4-Cyclopropylmethoxy-3,5-dimethoxy-PEA | Scaline | 60–80 mg | 12–18 hours | [37] |
| 38 | 2C-Se | 4-Methylseleno-2,5-dimethoxy-PEA | 2C | ~100 mg | 6–8 hours | [38] |
| 39 | 2C-T | 4-Methylthio-2,5-dimethoxy-PEA | 2C | 60–100 mg | 3–5 hours | [39] |
| 40 | 2C-T-2 | 4-Ethylthio-2,5-dimethoxy-PEA | 2C | 12–25 mg | 6–8 hours | [40] |
| 41 | 2C-T-4 | 4-Isopropylthio-2,5-dimethoxy-PEA | 2C | 8–20 mg | 12–18 hours | [41] |
| 42 | Psi-2C-T-4 (ψ-2C-T-4) | 4-Isopropylthio-2,6-dimethoxy-PEA | ψ-PEA | >12 mg | "Probably short" | [42] |
| 43 | 2C-T-7 | 4-Propylthio-2,5-dimethoxy-PEA | 2C | 10–30 mg | 8–15 hours | [43] |
| 44 | 2C-T-8 | 4-Cyclopropylmethylthio-2,5-dimethoxy-PEA | 2C | 30–50 mg | 10–15 hours | [44] |
| 45 | 2C-T-9 | 4-(t)-Butylthio-2,5-dimethoxy-PEA | 2C | 60–100 mg | 12–18 hours | [45] |
| 46 | 2C-T-13 | 4-(2-Methoxyethylthio)-2,5-dimethoxy-PEA | 2C | 25–40 mg | 6–8 hours | [46] |
| 47 | 2C-T-15 | 4-Cyclopropylthio-2,5-dimethoxy-PEA | 2C | >30 mg | "Several hours" | [47] |
| 48 | 2C-T-17 | 4-(s)-Butylthio-2,5-dimethoxy-PEA | 2C | 60–100 mg | 10–15 hours | [48] |
| 49 | 2C-T-21 | 4-(2-Fluoroethylthio)-2,5-dimethoxy-PEA | 2C | 8–12 mg | 7–10 hours | [49] |
| 50 | 4-D (4-trideuteromescaline) | 4-Trideuteromethyl-3,5-dimethoxy-PEA | Scaline | ~200–400 mgc | 12 hours | [50] |
| 51 | Beta-D (β,β-dideuteromescaline) | β,β-Dideutero-3,4,5-trimethoxy-PEA | Scaline | ~200–400 mgc | 12 hours | [51] |
| 52 | DESOXY (4-desoxymescaline) | 4-Methyl-3,5-dimethoxy-PEA | Scaline (mod.) | 40–120 mg | 6–8 hours | [52] |
| 53 | 2,4-DMA | 2,4-Dimethoxy-A | Other | >60 mg | "Short" | [53] |
| 54 | 2,5-DMA (DOH) | 2,5-Dimethoxy-A | DOx | 80–160 mg | 6–8 hours | [54] |
| 55 | 3,4-DMA (DMA) | 3,4-Dimethoxy-A | Other | "A few [100 mg]" | Unknown | [55] |
| 56 | DMCPA | 2,5-Dimethoxy-4-methyl-PCPA | DOx (mod.) | 15–20 mg | 4–8 hours | [56] |
| 57 | DME (β-hydroxy-3,4-DMPEA) | 3,4-Dimethoxy-β-hydroxy-PEA | BOx, other | >115 mg | Unknown | [57] |
| 58 | DMMDA (2,5-dimethoxy-MDA) | 2,5-Dimethoxy-3,4-methylenedioxy-A | MDxx | 30–75 mg | 6–8 hours | [58] |
| 59 | DMMDA-2 (5,6-dimethoxy-MDA) | 2,3-Dimethoxy-4,5-methylenedioxy-A | MDxx | ~50 mg | Unknown | [59] |
| 60 | DMPEA (3,4-DMPEA) | 3,4-Dimethoxy-PEA | Other | >1,000 mg | Unknown | [60] |
| 61 | DOAM | 4-Amyl-2,5-dimethoxy-A | DOx | >10 mg | Unknown | [61] |
| 62 | DOB | 4-Bromo-2,5-dimethoxy-A | DOx | 1–3 mg | 18–30 hours | [62] |
| 63 | DOBU | 4-Butyl-2,5-dimethoxy-A | DOx | Uncertain | "Very long" | [63] |
| 64 | DOC | 4-Chloro-2,5-dimethoxy-A | DOx | 1.5–3 mg | 12–24 hours | [64] |
| 65 | DOEF | 4-(2-Fluoroethyl)-2,5-dimethoxy-A | DOx | 2–3.5 mg | 12–16 hours | [65] |
| 66 | DOET | 4-Ethyl-2,5-dimethoxy-A | DOx | 2–6 mg | 14–20 hours | [66] |
| 67 | DOI | 4-Iodo-2,5-dimethoxy-A | DOx | 1.5–3 mg | 16–30 hours | [67] |
| 68 | DOM (STP) | 4-Methyl-2,5-dimethoxy-A | DOx | 3–10 mg | 14–20 hours | [68] |
| 69 | Psi-DOM (ψ-DOM) | 4-Methyl-2,6-dimethoxy-A | ψ-PEA | 15–25 mg | 6–8 hours | [69] |
| 70 | DON | 4-Nitro-2,5-dimethoxy-A | DOx | 3–4.5 mg | 8–15 hours | [70] |
| 71 | DOPR | 4-Propyl-2,5-dimethoxy-A | DOx | 2.5–5 mg | 20–30 hours | [71] |
| 72 | E (escaline) | 4-Ethoxy-3,5-dimethoxy-PEA | Scaline | 40–60 mg | 8–12 hours | [72] |
| 73 | EEE | 2,4,5-Triethoxy-A | DOx (mod.) | Unknown | Unknown | [73] |
| 74 | EEM | 2,4-Diethoxy-5-methoxy-A | DOx (mod.) | Unknown | Unknown | [74] |
| 75 | EME | 2,5-Diethoxy-4-methoxy-A | DOx (mod.) | Unknown | Unknown | [75] |
| 76 | EMM | 2-Ethoxy-4,5-dimethoxy-A | DOx (mod.) | >50 mg | Unknown | [76] |
| 77 | ETHYL-J (EBDB) | N,α-Diethyl-3,4-methylenedioxy-PEA | MDxx | >90 mg | "Probably short" | [77] |
| 78 | ETHYL-K (EBDP) | N-Ethyl-α-propyl-3,4-methylenedioxy-PEA | MDxx | >40 mg | Unknown | [78] |
| 79 | F-2 | 2-Methyl-5-methoxy-2,3-dihydro-6-APBF | Benzofuran | >15 mg | Unknown | [79] |
| 80 | F-22 | 2,2-Dimethyl-5-methoxy-2,3-dihydro-6-APBF | Benzofuran | >15 mg | Unknown | [80] |
| 81 | FLEA (MDMOH) | N-Hydroxy-N-methyl-3,4-methylenedioxy-A | MDxx | 100–160 mg | 4–8 hours | [81] |
| 82 | G-3 | 3,4-Trimethylene-2,5-dimethoxy-A | DOx (mod.) | 12–18 mg | 8–12 hours | [82] |
| 83 | G-4 | 3,4-Tetramethylene-2,5-dimethoxy-A | DOx (mod.) | Unknown | Unknown | [83] |
| 84 | G-5 | 3,4-Norbornyl-2,5-dimethoxy-A | DOx (mod.) | 14–20 mg | 16–30 hours | [84] |
| 85 | GANESHA (G; 3-methyl-DOM) | 3,4-Dimethyl-2,5-dimethoxy-A | DOx | 20–32 mg | 18–24 hours | [85] |
| 86 | G-N | 1,4-Dimethoxynaphthyl-2-isopropylamine | DOx (mod.) | Unknown | Unknown | [86] |
| 87 | HOT-2 (N-hydroxy-2C-T-2) | 2,5-Dimethoxy-N-hydroxy-4-ethylthio-PEA | HOT-x, 2C | 10–18 mg | 6–10 hours | [87] |
| 88 | HOT-7 (N-hydroxy-2C-T-7) | 2,5-Dimethoxy-N-hydroxy-4-(n)-propylthio-PEA | HOT-x, 2C | 15–25 mg | 6–8 hours | [88] |
| 89 | HOT-17 (N-hydroxy-2C-T-17) | 2,5-Dimethoxy-N-hydroxy-4-(s)-butylthio-PEA | HOT-x, 2C | 70–120 mg | 12–18 hours | [89] |
| 90 | IDNNA (N,N-dimethyl-DOI) | 2,5-Dimethoxy-N,N-dimethyl-4-iodo-A | DOx | >2.6 mg | Unknown | [90] |
| 91 | IM (isomescaline) | 2,3,4-Trimethoxy-PEA | Scaline (mod.) | >400 mg | Unknown | [91] |
| 92 | IP (isoproscaline) | 3,5-Dimethoxy-4-isopropoxy-PEA | Scaline (mod.) | 40–80 mg | 10–16 hours | [92] |
| 93 | IRIS | 5-Ethoxy-2-methoxy-4-methyl-A | DOx (mod.) | >9 mg | Unknown | [93] |
| 94 | J (BDB) | α-Ethyl-3,4-methylenedioxy-PEA | MDxx | 150–230 mg | 4–8 hours | [94] |
| 95 | LOPHOPHINE (MMDPEA) | 3-Methoxy-4,5-methylenedioxy-PEA | MDxx | >200 mg | Unknown | [95] |
| 96 | M (mescaline; 3,4,5-TMPEA) | 3,4,5-Trimethoxy-PEA | Scaline | ~200–400 mgc | 10–12 hours | [96] |
| 97 | 4-MA (PMA) | 4-Methoxy-A | Other | 50–80 mg | "Short" | [97] |
| 98 | MADAM-6 (6-methyl-MDMA) | 2,N-Dimethyl-4,5-methylenedioxy-A | MDxx | >280 mg | Unknown | [98] |
| 99 | MAL (methallylescaline) | 3,5-Dimethoxy-4-methallyloxy-PEA | Scaline | 40–65 mg | 12–16 hours | [99] |
| 100 | MDA | 3,4-Methylenedioxy-A | MDxx | 80–160 mg | 4–6 hoursd | [100] |
| 101 | MDAL | N-Allyl-3,4-methylenedioxy-A | MDxx | >180 mg | Unknown | [101] |
| 102 | MDBU | N-Butyl-3,4-methylenedioxy-A | MDxx | >40 mg | Unknown | [102] |
| 103 | MDBZ | N-Benzyl-3,4-methylenedioxy-A | MDxx | >150 mg | Unknown | [103] |
| 104 | MDCPM | N-Cyclopropylmethyl-3,4-methylenedioxy-A | MDxx | >10 mg | Unknown | [104] |
| 105 | MDDM | N,N-Dimethyl-3,4-methylenedioxy-A | MDxx | >150 mg | Unknown | [105] |
| 106 | MDE (MDEA) | N-Ethyl-3,4-methylenedioxy-A | MDxx | 100–200 mg | 3–5 hours | [106] |
| 107 | MDHOET | N-(2-Hydroxyethyl)-3,4-methylenedioxy-A | MDxx | >50 mg | Unknown | [107] |
| 108 | MDIP | N-Isopropyl-3,4-methylenedioxy-A | MDxx | >250 mg | Unknown | [108] |
| 109 | MDMA | N-Methyl-3,4-methylenedioxy-A | MDxx | 80–150 mg | 4–6 hours | [109] |
| 110 | MDMC (EDMA) | N-Methyl-3,4-ethylenedioxy-A | EDxx | ≥200 mg | 3–5 hours | [110] |
| 111 | MDMEO | N-Methoxy-3,4-methylenedioxy-A | MDxx | >180 mg | Unknown | [111] |
| 112 | MDMEOET | N-(2-Methoxyethyl)-3,4-methylenedioxy-A | MDxx | >180 mg | Unknown | [112] |
| 113 | MDMP | α,α,N-Trimethyl-3,4-methylenedioxy-PEA | MDxx | ~110 mg | ~6 hours | [113] |
| 114 | MDOH | N-Hydroxy-3,4-methylenedioxy-A | MDxx | 100–160 mg | 3–6 hours | [114] |
| 115 | MDPEA | 3,4-Methylenedioxy-PEA | MDxx | >300 mg | Unknown | [115] |
| 116 | MDPH | α,α-Dimethyl-3,4-methylenedioxy-PEA | MDxx | 160–240 mg | 3–5 hours | [116] |
| 117 | MDPL | N-Propargyl-3,4-methylenedioxy-A | MDxx | >150 mg | Unknown | [117] |
| 118 | MDPR | N-Propyl-3,4-methylenedioxy-A | MDxx | >200 mg | Unknown | [118] |
| 119 | ME (metaescaline) | 3,4-Dimethoxy-5-ethoxy-PEA | Scaline (mod.) | 200–350 mg | 8–12 hours | [119] |
| 120 | MEDA (5-methoxy-EDA) | 3-Methoxy-4,5-ethylenedioxy-A | EDxx | >200 mg | Unknown | [120] |
| 121 | MEE | 2-Methoxy-4,5-diethoxy-A | DOx (mod.) | >4.6 mg | Unknown | [121] |
| 122 | MEM | 2,5-Dimethoxy-4-ethoxy-A | DOx | 20–50 mg | 10–14 hours | [122] |
| 123 | MEPEA | 3-Methoxy-4-ethoxy-PEA | Other | ≥300 mg | "Short" | [123] |
| 124 | Meta-DOB | 5-Bromo-2,4-dimethoxy-A | DOx (mod.) | 50–100 mg | 5–6 hours | [124] |
| 125 | Meta-DOT | 5-Methylthio-2,4-dimethoxy-A | DOx (mod.) | >35 mg | Unknown | [125] |
| 126 | Methyl-DMA (N-methyl-2,5-DMA) | N-Methyl-2,5-dimethoxy-A | DOx | >250 mg | Unknown | [126] |
| 127 | Methyl-DOB (N-methyl-DOB) | 4-Bromo-2,5-dimethoxy-N-methyl-A | DOx | >8 mg | "Probably long" | [127] |
| 128 | Methyl-J (MBDB) | N-Methyl-α-ethyl-3,4-methylenedioxy-PEA | MDxx | 180–210 mg | 4–6 hours | [128] |
| 129 | Methyl-K (MBDP) | N-Methyl-α-propyl-3,4-methylenedioxy-PEA | MDxx | >100 mg | Unknown | [129] |
| 130 | Methyl-MA (PMMA) | N-Methyl-4-methoxy-A | Other | >100 mg | "Short" | [130] |
| 131 | Methyl-MMDA-2 (6-methoxy-MDMA) | N-Methyl-2-methoxy-4,5-methylenedioxy-A | MDxx | >70 mg | Unknown | [131] |
| 132 | MMDA (5-methoxy-MDA) | 3-Methoxy-4,5-methylenedioxy-A | MDxx | 100–250 mg | "Moderate" | [132] |
| 133 | MMDA-2 (6-methoxy-MDA) | 2-Methoxy-4,5-methylenedioxy-A | MDxx | 25–50 mg | 8–12 hours | [133] |
| 134 | MMDA-3a (2-methoxy-MDA) | 2-Methoxy-3,4-methylenedioxy-A | MDxx | 20–80 mg | 10–16 hours | [134] |
| 135 | MMDA-3b (4-methoxy-2,3-MDA) | 4-Methoxy-2,3-methylenedioxy-A | MDxx | >80 mg | Unknown | [135] |
| 136 | MME | 2,4-Dimethoxy-5-ethoxy-A | DOx (mod.) | ≥40 mg | ~6–10 hours | [136] |
| 137 | MP (metaproscaline) | 3,4-Dimethoxy-5-propoxy-PEA | Scaline (mod.) | >240 mg | Unknown | [137] |
| 138 | MPM | 2,5-Dimethoxy-4-propoxy-A | DOx | ≥30 mg | "Probably short" | [138] |
| 139 | Ortho-DOT | 2-Methylthio-4,5-dimethoxy-A | DOx (mod.) | >25 mg | Unknown | [139] |
| 140 | P (proscaline) | 3,5-Dimethoxy-4-propoxy-PEA | Scaline | 30–60 mg | 8–12 hours | [140] |
| 141 | PE (phenescaline) | 3,5-Dimethoxy-4-phenethyloxy-PEA | Scaline | >150 mg | Unknown | [141] |
| 142 | PEA (phenethylamine) | PEA | Other | >1,600 mg | Unknown | [142] |
| 143 | PROPYNYL (propynylscaline) | 4-Propynyloxy-3,5-dimethoxy-PEA | Scaline | ≥80 mg | 8–12 hours | [143] |
| 144 | SB (symbescaline) | 3,5-Diethoxy-4-methoxy-PEA | Scaline (mod.) | >240 mg | Unknown | [144] |
| 145 | TA (TeMA) | 2,3,4,5-Tetramethoxy-A | Other | >~50 mg | Unknown | [145] |
| 146 | 3-TASB (3-thioasymbescaline) | 4-Ethoxy-3-ethylthio-5-methoxy-PEA | Scaline (mod.) | ~160 mg | 10–18 hours | [146] |
| 147 | 4-TASB (4-thioasymbescaline) | 3-Ethoxy-4-ethylthio-5-methoxy-PEA | Scaline (mod.) | 60–100 mg | 10–15 hours | [147] |
| 148 | 5-TASB (5-thioasymbescaline) | 3,4-Diethoxy-5-methylthio-PEA | Scaline (mod.) | ~160 mg | ~8 hours | [148] |
| 149 | TB (thiobuscaline) | 4-Thiobutoxy-3,5-dimethoxy-PEA | Scaline (mod.) | 60–120 mg | ~8 hours | [149] |
| 150 | 3-TE (3-thioescaline) | 4-Ethoxy-5-methoxy-3-methylthio-PEA | Scaline (mod.) | 60–80 mg | 8–12 hours | [150] |
| 151 | 4-TE (4-thioescaline) | 3,5-Dimethoxy-4-ethylthio-PEA | Scaline (mod.) | 20–30 mg | 9–12 hours | [151] |
| 152 | 2-TIM (2-thioisomescaline) | 2-Methylthio-3,4-dimethoxy-PEA | Scaline (mod.) | >240 mg | Unknown | [152] |
| 153 | 3-TIM (3-thioisomescaline) | 3-Methylthio-2,4-dimethoxy-PEA | Scaline (mod.) | >240 mg | Unknown | [153] |
| 154 | 4-TIM (4-thioisomescaline) | 4-Methylthio-2,3-dimethoxy-PEA | Scaline (mod.) | >160 mg | Unknown | [154] |
| 155 | 3-TM (3-thiomescaline) | 3-Methylthio-4,5-dimethoxy-PEA | Scaline (mod.) | 60–100 mg | 8–12 hours | [155] |
| 156 | 4-TM (4-thiomescaline) | 4-Methylthio-3,5-dimethoxy-PEA | Scaline (mod.) | 20–40 mg | 10–15 hours | [156] |
| 157 | TMA (α-methylmescaline) | 3,4,5-Trimethoxy-A | 3C-scaline | 100–250 mg | 6–8 hours | [157] |
| 158 | TMA-2 (DOMeO) | 2,4,5-Trimethoxy-A | DOx | 20–40 mg | 8–12 hours | [158] |
| 159 | TMA-3 | 2,3,4-Trimethoxy-A | Other | >100 mg | Unknown | [159] |
| 160 | TMA-4 | 2,3,5-Trimethoxy-A | Other | >80 mg | ~6 hours | [160] |
| 161 | TMA-5 | 2,3,6-Trimethoxy-A | Other | ≥30 mg | 8–10 hours | [161] |
| 162 | TMA-6 (ψ-TMA-2) | 2,4,6-Trimethoxy-A | ψ-PEA | 25–50 mg | 12–16 hours | [162] |
| 163 | 3-TME (3-thiometaescaline) | 4,5-Dimethoxy-3-ethylthio-PEA | Scaline (mod.) | 60–100 mg | 10–15 hours | [163] |
| 164 | 4-TME (4-thiometaescaline) | 3-Ethoxy-5-methoxy-4-methylthio-PEA | Scaline (mod.) | 60–100 mg | 10–15 hours | [164] |
| 165 | 5-TME (5-thiometaescaline) | 3-Ethoxy-4-methoxy-5-methylthio-PEA | Scaline (mod.) | >200 mg | Unknown | [165] |
| 166 | 2T-MMDA-3a (2-methylthio-MDA) | 2-Methylthio-3,4-methylenedioxy-A | MDxx | >12 mg | Unknown | [166] |
| 167 | 4T-MMDA-2 (4-thio-MMDA-2) | 4,5-Thiomethyleneoxy-2-methoxy-A | MDxx (mod.) | >25 mg | Unknown | [167] |
| 168 | TMPEA (2,4,5-TMPEA; 2C-O) | 2,4,5-Trimethoxy-PEA | 2C | >300 mg | Unknown | [168] |
| 169 | 2-TOET | 4-Ethyl-5-methoxy-2-methylthio-A | DOx (mod.) | >65 mg | Unknown | [169] |
| 170 | 5-TOET | 4-Ethyl-2-methoxy-5-methylthio-A | DOx (mod.) | 12–25 mg | 8–24 hours | [170] |
| 171 | 2-TOM | 5-Methoxy-4-methyl-2-methylthio-A | DOx (mod.) | 60–100 mg | 8–10 hours | [171] |
| 172 | 5-TOM | 2-Methoxy-4-methyl-5-methylthio-A | DOx (mod.) | 30–50 mg | 6–10 hours | [172] |
| 173 | TOMSO | 2-Methoxy-4-methyl-5-methylsulfinyl-A | DOx (mod.) | ≥100–150 mge | 10–16 hours | [173] |
| 174 | TP (thioproscaline) | 4-Propylthio-3,5-dimethoxy-PEA | Scaline (mod.) | 20–25 mg | 10–15 hours | [174] |
| 175 | TRIS (trisescaline) | 3,4,5-Triethoxy-PEA | Scaline (mod.) | >240 mg | Unknown | [175] |
| 176 | 3-TSB (3-thiosymbescaline) | 3-Ethoxy-5-ethylthio-4-methoxy-PEA | Scaline (mod.) | >200 mg | Unknown | [176] |
| 177 | 4-TSB (4-thiosymbescaline) | 3,5-Diethoxy-4-methylthio-PEA | Scaline (mod.) | >240 mg | Unknown | [177] |
| 178 | 3-T-TRIS (3-thiotrisescaline) | 4,5-Diethoxy-3-ethylthio-PEA | Scaline (mod.) | >160 mg | Unknown | [178] |
| 179 | 4-T-TRIS (4-thiotrisescaline) | 3,5-Diethoxy-4-ethylthio-PEA | Scaline (mod.) | >200 mg | Unknown | [179] |
| Acronyms (in chemical names): PEA =phenethylamine; A =amphetamine; PCPA =2-phenylcyclopropylamine; 6-APBF =6-(2-aminopropyl)benzofuran.Footnotes:a =Dose andduration for compounds areorally unless otherwise specified.b =Ariadne dose is as apsychedelic. Otherwise doses of 12–32 mg as theracemate and 25 mg as (R)-Ariadne were active.c =4-D,beta-D, andmescaline doses are 200–400 mg as thesulfatesalt and 178–356 mg as thehydrochloride salt.d =MDA duration was originally 8–12 hours but was later revised by Shulgin to 4–6 hours in September 2001 following the publication ofPiHKAL.e =TOMSO dose is >150 mg alone or 100–150 mg withalcohol. | ||||||
In addition toPiHKAL, Shulgin has also described the properties of psychedelic phenethylamines in humans inliterature reviews.[13][14][15][16][17][18]
Prior to its use being criminalised, mescaline (4) also played a significant role in the development of the synthetic phenethylamines by inspiring the investigations of medicinal chemist Alexander Shulgin. Shulgin synthesised at least 179 phenethylamines, which he then tested either alone on himself or along with his wife and close friends, referred to as the 'research group'.[85 ] This work established some structure–psychoactivity relationships for phenethylamines in humans and resulted in the discovery of a number of substituted phenethylamines that remain important, such as the 'classic hallucinogens' DOM (2,5-dimethoxy-4-methylamphetamine; 40) and 2C-B (2,5-dimethoxy-4-bromophenethylamine; 44, Fig. 10), and entactogens MDEA (3,4-methylenedioxy-N-ethylamphetamine; 38) and MBDB (N-methyl-1-(benzodioxol-5-yl)butan-2-amine; 36, Fig. 9). Alexander (Sasha) and Ann Shulgin's book Phenethylamines I have known and loved (PiHKAL)[85] is a seminal work that contains frank and detailed descriptions of the subjective effects of phenethylamines and remains extremely valuable to current phenethylamine research.
More ambitious explorations of subjective effects elicited by a series of new psychoactive substances developed by Shulgin were conducted by his close associate and psychologist, Myron Stolaroff. Following SEs with LSD in the mid-1950s, Stolaroff became involved in scientific research on psychedelics. After the control of most psychedelic drugs in the 1970s, Stolaroff conducted SEs with newly synthesized psychedelics 2C-B, 2C-E, 2C-T-2, 2C-T-7, 2C-T4, 2C-T-21, and MEM but also MDMA. Besides Shulgin, Stolaroff was the first who systematically explored the psychological states and their possible uses but under noncontrolled conditions (Stolaroff 1994). He understood his research as an attempt "to make the unconscious conscious" and to give some "guidelines for the proper and safe use of psychedelic drugs in therapy and for spiritual growth" (Stolaroff 1994, pp. 13–14).